Fumihiko Watanabe

Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2):  <i>N</i>-Sulfonylamino Acid Derivatives

Yoshinori Tamura, Fumihiko Watanabe, Takuji Nakatani et al. · Journal of Medicinal Chemistry · 1998 · 283 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Pyrrolidine Inhibitors of Human Cytosolic Phospholipase A₂

Kaoru Seno, Takayuki Okuno, Koichi Nishi et al. · Journal of Medicinal Chemistry · 2000 · 158 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Selective reduction of aryl halides and .alpha.,.beta.-unsaturated esters with sodium borohydride-cuprous chloride in methanol and its application to deuterium labeling

Masayuki Narisada, Isao Horibe, Fumihiko Watanabe et al. · The Journal of Organic Chemistry · 1989 · 124 citations

Natural Sciences, Chemistry, Analytical Chemistry +6

Homology Modeling of Gelatinase Catalytic Domains and Docking Simulations of Novel Sulfonamide Inhibitors

Ryuichi Kiyama, Yoshinori Tamura, Fumihiko Watanabe et al. · Journal of Medicinal Chemistry · 1999 · 97 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (.+-.)-(5Z)-7-[3-endo[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-exo-yl]heptenoic acid

Masayuki Narisada, Mitsuaki Ohtani, Fumihiko Watanabe et al. · Journal of Medicinal Chemistry · 1988 · 82 citations

Medicine, Medicinal Chemistry, Pharmacology +5